All In Biotech

Free tool

FAERS Monitor: Bridion

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022225 or its brand name (Bridion, Sugammadex Sodium). Reports on generic versions are filed under their own applications.

Reports

2,731

Serious

2,306

84% of reports

Hospitalization

935

Death reported

104

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • anaphylactic reaction315
  • bradycardia285
  • cardiac arrest195
  • anaphylactic shock174
  • bronchospasm173
  • hypotension165
  • drug ineffective145
  • recurrence of neuromuscular blockade107
  • off label use96
  • oxygen saturation decreased95
  • drug interaction78
  • dyspnoea71
  • blood pressure decreased67
  • hypoxia67
  • tachycardia57

Reports by year received

View as table
YearReports
20101
20114
201234
201350
201435
201549
2016204
2017226
2018286
2019274
2020225
2021209
2022217
2023255
2024240
2025272
2026150

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,428 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
recurrence of neuromuscular blockadeSignal10712887.49476.4511,209
bronchospasmSignal17394.581.715,727
anaphylactic shockSignal17452.345.38,663
anaphylactic reactionSignal31544.239.813,201
bradycardiaSignal28541.637.311,225
cardiac arrestSignal19518.215.93,163
hypoxiaSignal6714.711.6840
oxygen saturation decreasedSignal9513.010.71,045
blood pressure decreasedSignal677.86.1389
hypotensionSignal1656.35.5743
tachycardiaSignal574.93.8176
drug interactionSignal783.83.0158
dyspnoea711.00.80
drug ineffective1450.80.74
off label use960.80.73

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.